Intrinsiqq
Lightbridge Corporation logo

Lightbridge Corporation Insider Trading

LTBR

⊜ Compare
Last 12 months

Insiders sold $1.23M and bought nothing on the open market.

89% of the selling was scheduled in advance under 10b5-1 plans. Director Mark Robert Tobin sold 135K on Aug 11, 18% of their stake, outside a plan. The last open-market buy by an executive or director was in Dec 2018.

Net open-market
−$1.23M
0 buys · 15 sales
Under a 10b5-1 plan
89%
of the value sold
Insiders who bought / sold
0 / 6
executives and directors
Last open-market buy
Dec 2018
Dec 20, 2018

Get an email when LTBR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 110b5-1 plan
    Sherri Goodman
    Director · sold 1,116 at $6.29
    7K
    1.6% of stake
  • Sep 110b5-1 plan
    Sweta Chakraborty
    Director · sold 717 at $7.43
    5K
    1.2% of stake
  • Aug 11No plan
    Mark Robert Tobin
    Director · sold 15,000 at $8.99
    135K
    18% of stake
  • Jul 110b5-1 plan
    Sweta Chakraborty
    Director · sold 1,143 at $9.29
    11K
    2.3% of stake
  • Jul 110b5-1 plan
    Sherri Goodman
    Director · sold 1,116 at $9.29
    10K
    1.8% of stake
  • Jun 2210b5-1 plan
    Sherri Goodman
    Director · sold 1,116 at $9.58
    11K
    1.8% of stake
  • Jan 2910b5-1 plan
    Andrey Mushakov
    EVP, Nuclear Operations · sold 30,289 at avg $16.57
    502K
    7.2% of stake
  • Jan 14 – 1510b5-1 plan
    Larry Goldman
    CFO · sold 8,869 at avg $18.05
    160K
    2.6% of stake
  • Jan 910b5-1 plan
    Jesse L. Funches
    Director · sold 1,449 at $16.96
    25K
    1.9% of stake
  • Jan 610b5-1 plan
    Sweta Chakraborty
    Director · sold 1,245 at $15.68
    20K
    2.5% of stake
  • Jan 210b5-1 plan
    Sweta Chakraborty
    Director · sold 1,947 at $12.88
    25K
    3.7% of stake
  • Dec 16, 202510b5-1 plan
    Larry Goldman
    CFO · sold 5,451 at $14.50
    79K
    1.6% of stake
  • Dec 5, 202510b5-1 plan
    Larry Goldman
    CFO · sold 8,030 at $17.50
    141K
    2.2% of stake
  • Dec 1, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,948 at $15.47
    30K
    4.5% of stake
  • Nov 20, 202510b5-1 plan
    Larry Goldman
    CFO · sold 4,527 at $15.22
    69K
    1.4% of stake
  • Nov 3, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,948 at $26.73
    52K
    4.3% of stake
  • Oct 15, 202510b5-1 plan
    Seth Grae
    President and CEO · sold 32,296 at $28.07
    907K
    4.1% of stake
  • Oct 13, 202510b5-1 plan
    Seth Grae
    President and CEO · sold 20,600 at $26.01
    536K
    2.7% of stake
  • Oct 10, 202510b5-1 plan
    Seth Grae
    President and CEO · sold 7,616 at $25.84
    197K
    1.0% of stake
  • Oct 10, 202510b5-1 plan
    Andrey Mushakov
    EVP, Nuclear Operations · sold 25,093 at $25.06
    629K
    6.0% of stake
  • Oct 8, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,246 at $22.89
    29K
    2.7% of stake
  • Oct 7, 202510b5-1 plan
    Jesse L. Funches
    Director · sold 1,448 at $22.67
    33K
    2.2% of stake
  • Oct 1, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,947 at $20.85
    41K
    4.0% of stake
  • Sep 22, 202510b5-1 plan
    Andrey Mushakov
    EVP, Nuclear Operations · sold 17,598 at $20.04
    353K
    4.3% of stake
  • Sep 2, 202510b5-1 plan
    Mark Robert Tobin
    Director · sold 3,000 at $14.21
    43K
    4.7% of stake
  • Sep 2, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,948 at $14.22
    28K
    3.9% of stake
  • Aug 20, 202510b5-1 plan
    Sweta Chakraborty
    Director · sold 1,948 at $13.79
    27K
    6.0% of stake
  • Aug 15, 2025No plan
    Sweta Chakraborty
    Director · sold 20,000 at $15.15
    303K
    38% of stake
  • Aug 13, 202510b5-1 plan
    Larry Goldman
    CFO · sold 24,334 at $18.00
    438K
    13% of stake
  • Jun 9, 2025 – Jun 10, 202510b5-1 plan
    Larry Goldman
    CFO · sold 37,698 at avg $15.89
    599K
    17% of stake
  • Jun 2, 202510b5-1 plan
    Mark Robert Tobin
    Director · sold 3,000 at $15.42
    46K
    6.4% of stake
  • May 28, 202510b5-1 plan
    Seth Grae
    President and CEO · sold 16,146 at $17.42
    281K
    3.4% of stake
  • May 14, 2025No plan
    Daniel B Magraw
    Director · sold 44,139 at $11.99
    529K
    76% of stake
  • May 14, 202510b5-1 plan
    Sherri Goodman
    Director · sold 7,000 at $11.73
    82K
    18% of stake
  • May 12, 202510b5-1 plan
    Jesse L. Funches
    Director · sold 6,250 at $9.75
    61K
    12% of stake
  • Mar 28, 2025No plan
    Daniel B Magraw
    Director · sold 169 at $7.35
    1K
    0.3% of stake
  • Mar 20, 2025No plan
    Daniel B Magraw
    Director · sold 323 at $9.95
    3K
    0.6% of stake
  • Feb 12, 202510b5-1 plan
    Larry Goldman
    CFO · sold 18,303 at $14.09
    258K
    11% of stake
  • Feb 12, 202510b5-1 plan
    Andrey Mushakov
    EVP, Nuclear Operations · sold 30,000 at $14.58
    437K
    16% of stake
  • Jan 23, 202510b5-1 plan
    Andrey Mushakov
    EVP, Nuclear Operations · sold 45,070 at avg $8.97
    404K
    19% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LTBR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Industrial Inorganic Chemicals · Pick stocks to compare with LTBR

CompareIntrinsic value
HGASGlobal Gas Corp
$0.05+0.00%0
PLPLPlandai Biotechnology Inc.
$0.00+0.00%30
CFOOChina Foods Holdings Ltd.
$1.05+0.00%18
ATYRAtyr Pharma Inc.
$6.18-6.79%10
BIXTBioxytran Inc.
$0.02-2.84%25
CLDXCelldex Therapeutics Inc.
$29.93+0.74%10
LEXXLexaria Bioscience Corp.
$4.07+0.99%10
CLNNClene Inc.
$4.10+8.75%0

Held by ETFs

LTBR is in 8 US ETFs. The largest of them, with LTBR's weight in each:

Spot a number that looks wrong? Check it in LTBR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LTBR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.